BICO Endorses FDA Modernization Act of 2021
The legislation would end the mandate on animal testing for drug and cosmetic development in the United States and has the potential save the lives of hundreds of millions of animals each year BICO, a leading bio convergence company, announced today it is endorsing the bipartisan FDA Modernization Act of 2021. The bill, H.R. 2565 / S.2952, would allow drug and cosmetic makers to develop new products using non-animal models including cell-based assays, organ chips and micro physiological systems, sophisticated computer modelling, and other human biology-based test methods. Since its